Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Current Oncology (Toronto, Ont.)|August 13, 2009
Optimizing the management of advanced non-small-cell lung cancer: a personal viewM D VincentSouth African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|November 26, 1977
Immunodepression, ascites tumour and lactate dehydrogenase virusM D Vincent, J G Potter, S CooperBone Marrow Transplantation|December 1, 1986
Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anaemiaP Jacobs, M D Vincent, R W MartellDrug Metabolism and Disposition: the Biological Fate of Chemicals|November 26, 1999
Enhancement of platinum-drug cytotoxicity in a human head and neck squamous cell carcinoma line and its platinum-resistant variant by liposomal amphotericin B and phospholipase A2-IIP J Ferguson, C Currie, M D VincentEuropean Journal of Cancer & Clinical Oncology|November 1, 1987
Prognostic factors in small cell lung cancer: a simple prognostic index is better than conventional stagingM D Vincent, S E Ashley, I E SmithBritish Journal of Pharmacology|November 29, 2001
Antisense-induced down-regulation of thymidylate synthase and enhanced cytotoxicity of 5-FUdR in 5-FUdR-resistant HeLa cellsP J Ferguson, J M DeMoor, M D Vincent, et al.Experimental Cell Research|August 26, 1998
Antisense nucleic acids targeted to the thymidylate synthase (TS) mRNA translation start site stimulate TS gene transcriptionJ M DeMoor, M D Vincent, O M Collins, et al.Current Oncology (Toronto, Ont.)|July 13, 2012
Biomarkers that currently affect clinical practice: EGFR, ALK, MET, KRASM D Vincent, M S Kuruvilla, N B Leighl, et al.Cancer Chemotherapy and Pharmacology|January 1, 1988
Late intensification with high-dose melphalan and autologous bone marrow support in breast cancer patients responding to conventional chemotherapyM D Vincent, T J Powles, R C Coombes, et al.Pageof 3